Cargando…
Clinicopathological and prognostic significance of p16 protein in nasopharynx cancer patients: A PRISMA-compliant meta-analysis
BACKGROUND: p16 protein is significantly down-regulated in several cancers, which reveals that it may be a potential biomarker for cancers. However, the clinicopathological and prognostic value of p16 protein in nasopharynx cancer patients remains unclear. Therefore, we performed a meta-analysis to...
Autores principales: | Sun, Lingling, Song, Jingjing, Huang, Qingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426621/ https://www.ncbi.nlm.nih.gov/pubmed/30882625 http://dx.doi.org/10.1097/MD.0000000000014602 |
Ejemplares similares
-
Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis
por: Zhou, Ning, et al.
Publicado: (2018) -
Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Sun, Ping, et al.
Publicado: (2019) -
The prognostic and clinicopathological significance of RBM3 in the survival of patients with tumor: A Prisma-compliant meta-analysis
por: Gao, Guangyu, et al.
Publicado: (2020) -
Clinicopathological and prognostic role of ROC1 in neoplasms: A PRISMA-compliant systematic review and meta-analysis
por: Shen, Nirui, et al.
Publicado: (2022) -
The Prognostic Significance of Hsp70 in Patients with Colorectal Cancer Patients: A PRISMA-Compliant Meta-Analysis
por: Gao, Guangyu, et al.
Publicado: (2021)